Impact of Surgical Intervention on Nonobstructive Dysphagia: A Retrospective Study Based on High-Resolution Impedance Manometry in a Taiwanese Population at a Single Institution.
Gang-Hua LinKuan-Hsun LinSzu-Yu LinTsai-Wang HuangHung ChangHsu-Kai HuangPublished in: Journal of personalized medicine (2022)
Esophageal motility disorders account for a large proportion of nonobstructive dysphagia cases, which constitute a heterogeneous group of diagnoses that commonly result in peristaltic derangement and impaired relaxation of the lower esophageal sphincter. We performed a single-institution retrospective study enrolling consecutive patients with chief complaints of dysphagia who underwent HRIM from December 2014 to December 2019, and analyzed demographic, clinical, and manometric data using descriptive statistics. In total, 277 identified patients were included in the final analysis. Ineffective esophageal motility ( n = 152, 24.5%) was the most common diagnosis by HRIM, followed by absent contractility, EGJ outflow obstruction, type II achalasia, and type I achalasia. Furthermore, surgery including exploratory, laparoscopic, and robotic myotomy, as well as POEM, is considered the most effective treatment for patients with non-spastic achalasia and EGJOO, due to its effective symptom palliation and prevention of disease progression; surgery also contributes to an obvious improvement of dysphagia compared with slightly less efficacy for other related symptoms. Our study aimed to elaborate the clinical characteristics of patients with nonobstructive dysphagia based on HRIM in a Taiwanese population, and to analyze the therapeutic outcomes of such patients who ultimately underwent surgical interventions.
Keyphrases
- minimally invasive
- high resolution
- coronary artery bypass
- hypertrophic cardiomyopathy
- robot assisted
- randomized controlled trial
- end stage renal disease
- biofilm formation
- newly diagnosed
- ejection fraction
- mass spectrometry
- adipose tissue
- escherichia coli
- metabolic syndrome
- heart failure
- patient reported
- type diabetes
- coronary artery disease
- combination therapy
- cystic fibrosis
- magnetic resonance
- big data
- patient reported outcomes
- cross sectional
- single molecule
- insulin resistance
- weight loss
- data analysis
- liquid chromatography
- artificial intelligence
- botulinum toxin